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M. Hamish,* J. Shalhoub, C.D. Rodd and A.H. DaviesWest of London Vascular Service, Charing Cross Hospital, London W6 8RF, UKObjectives. To describe a series of venous surgical procedures performed to maintain vascular access.
Methods. We report eight patients with end-stage renal failure (ESRF) who had complex renal access problems. Three
patients had central venous occlusion and underwent veno-venous axillo-iliac bypass. In five further patients with a
symptomatic central venous obstruction we performed axillo-iliac arterio-venous grafting (AVGs) in order to achieve
haemodialysis access. All patients were assessed pre-operatively with duplex ultrasound and venogram of upper and lower
limbs. The axillary artery or vein, and iliac vein were approached via infraclavicular and extra-peritoneal groin incisions,
respectively. Non-externally-supported polytetrafluoroethylene (PTFE) was used as a conduit in all patients and anti-
coagulation regimen were commenced post-operatively.
Results. Following venous diversion surgery, there was a dramatic improvement in the facial and limb swelling experienced
by the patients. There was no significant peri-operative morbidity. The veno-venous graft is still patent at 14 months in
patient one, at 10 months in patient two, and 5 months in patient three. In the second group, who had arterio-venous grafts,
the mean follow-up was 13.2 (7–20) months with a secondary patency rate of 80% at 6 months. Four patients had patent,
usable grafts at 12 months. In two cases, graft occlusion was treated with successful thrombectomy.
Conclusion. Axillary-iliac veno-venous diversion can overcome the symptoms and complications of superior vena cava and
innominate vein obstruction. Although, axillo-iliac arterio-venous graft fistulae formation was previously described it has
not been widely used. We have found the procedure to have low morbidity and advocate its use in these complex cases.Keywords: Arterio-venous graft (AVG); Extra-anatomic AVG fistula; End-stage renal failure (ESRF).Introduction
Patients with end-stage renal failure (ESRF) on dialysis
frequently have complex central venous drainage
problems as the result of multiple venous access
procedures. In this instance, the patient will suffer two
serious problems. Firstly, poor venous drainage will
increase venous pressure and result in detrimental
effects on the function of any vascular access in upper
limbs.1 Furthermore, an occluded innominate vein
(INV) can cause severe symptomatic limb oedema,
and an occluded superior vena cava (SVC) can result
in facial and neck swelling.
Such patients, usually suffering multiple co-mor-
bidities, have exhausted conventional access options.
They, therefore, present a great challenge to the
interventional radiologist or the vascular surgeon. If
endoluminal procedures are unsuccessful, veno-
venous bypass will remain as the only alternative in
order to establish a suitable venous outflow. Theing author. M. Hamish, MD, FRCS, West of London
ice, Charing Cross Hospital, London W6 8RF, UK.
: mhamish@hotmail.com
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dependent on the patency of jugular or iliac veins,
with use of the SVC or right atrium as last resort—in
the knowledge that thoracotomy will be required.2 An
equally challenging situation is to provide a reliable
accessible dialysis access for patient where all
peripheral accesses sites have been exhausted. In this
instance, axillo-iliac arteriovenous bypass is a feasible
option.Patients and Methods
We undertook a cohort study over 2 years (2003–2005)
of eight ESRF patients, with mean age of 75.86G10.7
years. They had been on renal dialysis for 9.75 years
(5–13) and they had on average nine (6–12) vascular
access procedures during this time on dialysis. Three
patients had symptomatic central venous stenosis,
involving the innominate (INV) and SVC secondary to
previous dialysis central line procedures. In one case,
attempted SVC stenting had failed (Figs. 1 and 2).
Veno-venous axillo-iliac bypass was performed. FiveEur J Vasc Endovasc Surg 31, 530–534 (2006)
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Fig. 1. Venoplasty with stenting for right subclavian vein stenosis.
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asymptomatic central venous obstruction, due to
many previous central line insertions with failed
endovascular management to relieve venous obstruc-
tion. In this group of patients axillo-iliac arterio-
venous graft was created Table 1.
Inclusion criteria were consenting patients with
central venous occlusion causing intractable symptoms
and/or poor function of vascular access (low dialysis
follow !280 ml/min) with no possibility of creating
suitable peripheral fistulae. Exclusion criteria included
patients suitable for endovascular venoplasty, orwhereFig. 2. Stent migration to the superioperipheral access remained an option. The end points
were symptomatic relief of central venous obstruction,
and/or patency of the original or the created access
fistula as assessed by haemodialysis parameters.
Pre-operatively, all patients underwent clinical
assessment, bilateral blood pressure measurement,
arterial and venous duplex ultrasonography, and
venography of upper and lower extremities. Arterio-
graphy was used where appropriate. One patient from
the arterio-venous group had a right subclavian artery
stenosis, which was addressed by angioplasty pre-
operatively to ensure good inflow. Post-operatively,r vena cava with venous occlusion.
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Table 1. Patient characteristics
Patient Central venous
obstruction
Location of CV*
obstruction
Previous central liner Time on
dialysis (years)
Number of
previous access
Recent usable access
Rt Lt
P1 Symptomatic SVC† 2 2 12 12 Rt forearm straight graft
(radial radio-basilic)
P2 Symptomatic SVC 2 1 9 9 Lt basilic vein trans-
position
P3 Symptomatic SVC 4 1 9 8 Lt basilic vein trans-
position
P4 Asymptomatic SVC, R INV‡ 2 2 12 7 o
P5 Asymptomatic SVC, Lt INV 1 1 10 10 o
P6 Asymptomatic SVC, Lt INV 3 2 13 12 o
P7 Asymptomatic SVC, Rt INV 1 2 11 6 o
P8 Asymptomatic SVC, Rt INV 3 1 6 11 o
Rt, right side; Lt, left side.
* Central venous.
† Superior vena cava.
‡ Innominate vein.
M. Hamish et al.532bilateral blood pressures were repeated, along with
clinical assessment for steal syndrome, as well as anti-
coagulation with warfarin in all patients.
Exposure of subclavian vessels was via an infra-
clavicular incision. The iliac vessels were approached
extra-peritoneally, in a fashion similar to that used in
kidney transplantation. The grafts were tunnelled
subcutaneously along the anterior axillary line
(Fig. 3). No significant difficulty was encountered in
exposing the iliac vessels, despite the fact that two of
the patients had ipsilaterally-placed failed trans-
planted kidneys. These two patients had contralateral
side innominate venous occlusion, which forced us to
use the side of previous transplant. The iliac anasto-Fig. 3. Schematic representation of graft route from axillary
Eur J Vasc Endovasc Surg Vol 31, May 2006mosis was sited distally to the transplant site on the
external iliac veins. Non-externally supported poly-
tetrafluoroethylene (PTFE) grafts were utilised in all
patients with 6 mm graft for axillo-iliac veno-venous
bypass procedures and 7 mm for the arterio-venous
bypasses. The grafts were needled at 4–6 weeks post-
operation.Results
As a consequence of the venous diversion, there was
no significant peri-operative morbidity. A summary of
the results is shown in Table 2. In the first patient, therevein (1) and axillary artery (2) to external iliac vein (3).
Table 2. Procedure data
Patient Bypass Follow up/
months
Occlusion
at/months
Patent at
12 months
P1 Rt axillo-iliac
venovenous
14 C
P2 Lt axillo-iliac
venovenous
10
P3 Lt axillo-iliac
venovenous
5 4
P4 Lt axillo-iliac
arteriovenous
7 5
P5 Rt axillo-iliac
arteriovenous
13 C
P6 Rt axillo-iliac
arteriovenous
13 C
P7 Lt axillo-iliac
arteriovenous
20 C
P8 Lt axillo-iliac
arteriovenous
13 7 C
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swelling. The ipsilaterally-sited forearm straight graft,
which had been poorly functioning pre-operatively,
developed good flow and remains usable at 14 months
of follow-up Table 3 and Fig. 4.
The second and third patients were experiencing
severe left arm swelling and poor function of basilic
transposition fistulae. Post-operatively, the swelling
subsided. The fistulae exhibited good dialysis par-
ameters at 10 and 5 months, respectively. The third
patient experienced two occlusions of the graft on the
fourth post-operative day and at 4 months which were
treated by successful graft thrombectomy.
In the group of five patients who had axillo-iliac
fistulae, the mean follow-up was 13.2 (7–20) months.
The primary patency rate was 80% at 6 months. FourFig. 4. Arterio-venous fistulae flow ch
Table 3. Results in veno-venous diversion group showed
improved vascular access flow by at least 100 ml/min
Patients Central venous
obstruction
symptoms
Vascular access flow
ml/min!260
pre-operatively
Patent at
months
P1 Improved 380 14
P2 Improved 367 10
P3 Improved 358 5patients had patent usable grafts at 12 months. Patient
five has a patent, usable graft at 8 months post-
procedure. Two patients experienced graft occlusion,
and flowwas subsequently restored by thrombectomy.
Re-occlusion was not seen. The average blood flow
through the graft, checked 4 weeks post-operatively,
was 1.5 (1.1–3.1) l/min. There were no reports of
symptoms of steal syndrome in the upper extremities
of our patients. No significant discrepancy between
arm blood pressures developed. One patient, however,
did experience lower limb swelling on the side of the
fistula. This was not associated with deep venous
thrombosis, and resolved following conservative
management.Discussion
One of the greatest challenges to any vascular surgeon
is to provide reliable dialysis access in the ESRF
patient in whom traditional vascular access site
options are unavailable. The situation is complicated
by the presence of numerous co-morbidities. Central
venous stenosis or occlusion may be present, with the
potential for its own symptomatology. Functional
disability of the affected extremity is seen in approxi-
mately 75% of patients.1
Treatment options include closure of the fistula,
percutaneous transluminal angioplasty, and bypass of
the occluded vein segment. Ligation of the access is a
simple and effective method, but it destroys the
functional arterio-venous access in a patient critically
dependent on haemodialysis. It further renders the
limb unsuitable for future use as a vascular access
site.3
Cimochowski et al.4 published a series of nine
axillo-iliac graft fistulae in eight patients. Six out of
eight grafts were patent and usable at 12-month
follow-up. Two patients died before 12 months with
patent grafts. This group employed externally-sup-
ported PTFE, which was tunnelled beneath the
pectoralis muscle—a technique not employed in ourange after veno-venous diversion.
Eur J Vasc Endovasc Surg Vol 31, May 2006
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reported at 12 months. Mean arterial flow was
measured as 210 ml/min (150–255 ml/min), as
compared with 1.5 (1.1–3.1) l/min in our patients.
Hazinedarog˘lu et al.5 published a series of 27
centrally created AVF using the axillary artery as
inflow and the internal jugular vein as outflow.
Primary and secondary patency at 1 year was 33 and
57%, respectively. Karp et al.3 described an interesting
case of infra-renal and supra-superior vena caval pan-
venous occlusion. Access was achieved by the
formation of an axillo-renal fistula.
Kavallieratos et al.6 reported an 87% patency rate for
axillary to saphenous veno-venous bypass using 8 mm
PTFE grafts without ligation of the distal saphenous
vein. There was no significant peri-operative morbid-
ity, with good symptomatic improvement in all
patients. Furthermore, there was improved usability
of the associated vascular access.
We have found axillo-iliac veno-venous diversion
to be a safe and acceptable treatment option for the
symptoms and complications of central vein obstruc-
tion. Extra-anatomic arterio-venous fistula formation
is a safe and successful procedure in patients with
limited potential for alternative dialysis access.
Although previously described, this less invasiveEur J Vasc Endovasc Surg Vol 31, May 2006procedure has not been widely used. For both groups
of patients, with multiple co-morbidities, associated
complications were minimal and, as such, we advo-
cate the use of these techniques in similar complex
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